Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ZIMMER BIOMET HOLDINGS, INC.

(ZBH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Zimmer Biomet : Barclays Cuts Price Target on Zimmer Biomet to $186 From $210, Keeps Overweight Rating

10/05/2021 | 07:41am EST


ę MT Newswires 2021
All news about ZIMMER BIOMET HOLDINGS, INC.
12/07Loop Capital Starts Zimmer Biomet Holdings at Buy With $165 Price Target
MT
11/30ZIMMER BIOMET : Announces Early Results and Upsize of its Tender Offers for Certain Outsta..
PU
11/30ZIMMER BIOMET HOLDINGS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
11/30Zimmer Biomet Announces Early Results and Upsize of its Tender Offers for Certain Outst..
PR
11/30Zimmer Biomet Holdings, Inc. Announces Early Results and Upsize of its Tender Offers fo..
CI
11/24ZIMMER BIOMET HOLDINGS, INC. : Entry into a Material Definitive Agreement, Creation of a D..
AQ
11/24NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
11/23Argus Downgrades Zimmer Biomet Holdings to Hold From Buy
MT
11/18ZIMMER BIOMET HOLDINGS, INC. : Entry into a Material Definitive Agreement, Financial State..
AQ
11/18Zimmer Biomet to Present at Evercore ISI's 4th Annual HealthCONx Conference
PR
More news
Analyst Recommendations on ZIMMER BIOMET HOLDINGS, INC.
More recommendations
Financials (USD)
Sales 2021 7 877 M - -
Net income 2021 839 M - -
Net Debt 2021 6 446 M - -
P/E ratio 2021 32,8x
Yield 2021 0,75%
Capitalization 26 830 M 26 830 M -
EV / Sales 2021 4,22x
EV / Sales 2022 3,90x
Nbr of Employees 20 000
Free-Float 66,8%
Chart ZIMMER BIOMET HOLDINGS, INC.
Duration : Period :
Zimmer Biomet Holdings, Inc. Technical Analysis Chart | ZBH | US98956P1021 | MarketScreener
Technical analysis trends ZIMMER BIOMET HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 28
Last Close Price 128,43 $
Average target price 169,12 $
Spread / Average Target 31,7%
EPS Revisions
Managers and Directors
Bryan C. Hanson Chairman, President & Chief Executive Officer
Suketu P. Upadhyay Chief Financial Officer & Executive Vice President
Zeeshan Tariq Chief Information Officer & Senior Vice President
Nitin Goyal Chief Science, Technology & Innovation Officer
Ivan Tornos Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
ZIMMER BIOMET HOLDINGS, INC.-16.65%26 830
ABBOTT LABORATORIES20.94%234 157
MEDTRONIC PLC-4.16%150 954
BECTON, DICKINSON AND COMPANY0.06%71 108
HOYA CORPORATION29.61%58 237
DEXCOM, INC.51.03%54 121